Literature DB >> 31628466

Aldosterone Reduction Rate After Saline Infusion Test May Be a Novel Prediction in Patients With Primary Aldosteronism.

Hidekazu Nagano1,2, Takashi Kono2,3, Atsushi Saiga4, Yoshihiro Kubota4, Masanori Fujimoto2,3, Saulo J A Felizola1, Kazuki Ishiwata2,3, Ai Tamura2,3, Seiichiro Higuchi1,5, Ikki Sakuma2,3, Naoko Hashimoto1,2, Sawako Suzuki2,3, Hisashi Koide2,3, Nobushige Takeshita6, Shinichi Sakamoto6, Toshiaki Ban5, Koutaro Yokote2,3, Yasuhiro Nakamura7, Tomohiko Ichikawa6, Takashi Uno4, Tomoaki Tanaka1,2.   

Abstract

OBJECTIVE: Accurate assessment and localization of aldosterone-producing adenomas (APAs) are essential for the treatment of primary aldosteronism (PA). Although adrenal venous sampling (AVS) is the standard method of reference for subtype diagnosis in PA, controversy exists concerning the criteria for its interpretation. This study aims to determine better indicators that can reliably predict subtypes of PA.
METHOD: Retrospective, single-cohort analysis including 209 patients with PA who were subjected to AVS. Eighty-two patients whose plasma aldosterone concentrations (PAC) were normalized after surgery were histopathologically or genetically diagnosed with APA. The accuracy of image findings was compared to AVS results. Receiver operating characteristic (ROC) curve analysis between the operated and the no-apparent laterality groups was performed using AVS parameters and loading test for diagnosis of PA. RESULT: Agreement between image findings and AVS results was 56.3%. ROC curve analysis revealed that the lateralization index (LI) after adrenocorticotropin stimulation cutoff was 2.40, with 98.8% sensitivity and 97.1% specificity. The contralateral suppression index (CSI) cutoff value was 1.19, with 98.0% sensitivity and 93.9% specificity. All patients over the LI and CSI cutoff values exhibited unilateral subtypes. Among the loading test, the best classification accuracy was achieved using the PAC reduction rate after a saline infusion test (SIT) >33.8%, which yielded 87.2% sensitivity or a PAC after a SIT <87.9 pg/mL with 86.2% specificity for predicting bilateral PA.
CONCLUSION: The combined criteria of the PAC reduction rate and PAC after the SIT can determine which subset of patients with APA who should be performed AVS for validation. © Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  adrenal venous sampling; hypertension; primary aldosteronism; saline infusion test

Year:  2020        PMID: 31628466     DOI: 10.1210/clinem/dgz092

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

Review 1.  Adrenal venous sampling in the diagnostic workup of primary aldosteronism.

Authors:  Matthias Johannes Betz; Christoph Johannes Zech
Journal:  Br J Radiol       Date:  2021-10-07       Impact factor: 3.039

Review 2.  Primary aldosteronism - a multidimensional syndrome.

Authors:  Adina F Turcu; Jun Yang; Anand Vaidya
Journal:  Nat Rev Endocrinol       Date:  2022-08-31       Impact factor: 47.564

3.  Adrenal Venous Sampling Could Be Omitted before Surgery in Patients with Conn's Adenoma Confirmed by Computed Tomography and Higher Normal Aldosterone Concentration after Saline Infusion Test.

Authors:  Robert Holaj; Petr Waldauf; Dan Wichterle; Jan Kvasnička; Tomáš Zelinka; Ondřej Petrák; Zuzana Krátká; Lubomíra Forejtová; Jan Kaván; Jiří Widimský
Journal:  Diagnostics (Basel)       Date:  2022-07-15

4.  Evaluation of various confirmatory tests for the diagnosis of aldosterone-producing adenoma.

Authors:  Satoshi Kidoguchi; Naoki Sugano; Ruri Kawauchi; Daisuke Nakashima; Naomi Hayashi-Ishikawa; Goro Tokudome; Takashi Yokoo
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Apr-Jun       Impact factor: 1.636

Review 5.  Recent Development toward the Next Clinical Practice of Primary Aldosteronism: A Literature Review.

Authors:  Yuta Tezuka; Yuto Yamazaki; Yasuhiro Nakamura; Hironobu Sasano; Fumitoshi Satoh
Journal:  Biomedicines       Date:  2021-03-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.